RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) on November 25 and set a price target of $50.00. The ...

On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $42.05 which represents a decrease of $-1.61 or -3.69% from the prior close of $43.66. The stock opened at $43.13 and touched a ...

We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...

Shares of Moderna Inc. MRNA shed 3.69% to $42.05 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.63% to 19,174 ...

This segment is sponsored by the Altoona Center for Clinical Research ALTOONA, Pa. (WTAJ) — A Clinical Trial to Evaluate an ...

As the cold sets in and we are spending most of our time indoors with family and friends, we have to pay attention because a ...

The Nasdaq-100 index tracks the largest 100 non-financial companies on the Nasdaq stock exchange. Although it's not a part of the U.S. stock market's big three indexes (S&P 500, Nasdaq Composite, and ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

Moderna stock is undervalued with a $97 price target, strong COVID-19 revenue, promising pipeline, and long-term growth. Read ...

As the new administration prepares to take over, there will be no time to waste in tackling enormous challenges in a region ...

But if your plans to get the updated COVID-19 vaccine well before the holiday fell through, you may be wondering if it’s too ...

Schools participating in the Science Series program get an exclusive Mets-focused science curriculum to implement in their classrooms. The Mets provide teachers with six lesson plan topics to ...